Hot Features
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
ARLINGTON, Va., Nov. 16 /PRNewswire/ -- BioInformatics, LLC announced today the availability of a new report "Marketing to Life Scientists 2006: Capitalizing on Media Engagement." As a basis for...
New combined company creates the leading provider of products and services in the high-growth life, laboratory and health sciences industry WALTHAM, Mass., Nov. 9 /PRNewswire-FirstCall/...
NEW YORK, Nov. 6 /PRNewswire/ -- Standard & Poor's will make the following changes to the S&P 500, S&P MidCap 400 and S&P SmallCap 600 indices: * CB Richard Ellis Group Inc. (NYSE:CBG) will...
Sales of New Products Drive Increases Across the Company WALTHAM, Mass., Oct. 25 /PRNewswire-FirstCall/ -- Thermo Electron Corporation (NYSE:TMO) today reported revenue growth of 7% to $725...
Fisher Scientific International Inc. (NYSE: FSH), the world leader in serving science, today reported record sales and earnings for the third quarter ended Sept. 30, 2006...
WALTHAM, Mass. and HAMPTON, N.H., Oct. 17 /PRNewswire-FirstCall/ -- Thermo Electron Corporation (NYSE:TMO) and Fisher Scientific International Inc. (NYSE:FSH) today announced that the U.S...
Fisher Scientific International Inc. (NYSE: FSH) will issue a press release regarding its third-quarter and year-to-date results on Monday, Oct. 23, after the market closes...
Thermo Electron Corporation (NYSE: TMO) and Fisher Scientific International Inc. (NYSE: FSH) announced today that they have provided conversion-right notices to the holders of...
Fisher Scientific International Inc. (NYSE: FSH) today announced that it has received the required consents from note holders to execute supplemental indentures amending the indentures relating...
ARLINGTON, Va., Sept. 6 /PRNewswire/ -- According to the findings of a new report from BioInformatics, LLC, total spending by research scientists on synthetic DNA oligonucleotides (oligos) is...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
